Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Citadel Securities LLC(0.4%),Citadel Securities Group LP(0.4%)等
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(8.2%),Tang Capital Management, LLC(8.2%)等
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
Marinus Pharmaceuticals | 4:持股变动声明-高管 MANNING MARTHA E
Marinus Pharmaceuticals | 4:持股变动声明-高管 Shafer Christina
Marinus Pharmaceuticals | 4:持股变动声明-高管 Hulihan Joseph
Marinus Pharmaceuticals | 4:持股变动声明-高管 Pfanstiel Steven
Marinus Pharmaceuticals | 4:持股变动声明-高管 Braunstein Scott
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-LION POINT CAPITAL, LP(3.9%),LION POINT HOLDINGS GP, LLC(3.9%)等
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%)等
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Eventide Asset Management, LLC(8.30%),Finny Kuruvilla, M.D. Ph. D.(8.30%)等
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(0.9%),Point72 Capital Advisors, Inc.(0.9%)等
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(5.8%),Behzad Aghazadeh(5.8%)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%)等
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Jennison Associates LLC(5.4%)
Marinus Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Adage Capital Partners, L.P.(4.73%),Adage Capital Partners GP, L.L.C.(4.73%)等
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-Franklin Resources, Inc.(7.0%),Franklin Advisers, Inc.(7.0%)
Marinus Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(8.4%)
Marinus Pharmaceuticals | 4:持股变动声明-董事 Silverstein Christine Berni
暂无数据